Live feed
Filing
SC 13D
SC 13D0001104659-16-097511·BFAM Partners (Cayman) Ltd
Schedule 13D ownership disclosure
Carbylan Therapeutics, Inc.
Security class unavailable · CUSIP: 141384107
Event date: 2016-02-04
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 31,146,032
- Percent of class
- 9.9900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-16-097511
- Form type
- SC 13D
- Filer
- BFAM Partners (Cayman) Ltd
- CIK
- CIK 1639101
- Filed
- Feb 17, 2016
- Reporting period
- Feb 04, 2016
- Description
- Schedule 13D beneficial ownership